CLONAZEPAM

Generic: CLONAZEPAM

Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
CLONAZEPAMActive Substance
2019-06-28Original Approval

CLONAZEPAM is FDA application ANDA211033, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
10,488 reports
2
FATIGUE
7,452 reports
3
NAUSEA
6,743 reports
4
OFF LABEL USE
6,508 reports
5
HEADACHE
6,118 reports
6
PAIN
5,922 reports
7
ANXIETY
5,845 reports
8
DEPRESSION
5,626 reports
9
DYSPNOEA
5,583 reports
10
TOXICITY TO VARIOUS AGENTS
5,287 reports